Bedfordshire, Luton and Milton Keynes Area Prescribing Committee

Ref: APC Bulletin 213
Bulletin Date: 16/02/15
Review Date: February 2017


Bulletin 213 Eltrombopag (Revolade®) for the treatment of thrombocytopenia in adult patients with chronic hepatitis C virus infection

APC Recommendations:

Eltrombopag(Revolade) for the treatment of thrombocytopenia in adult patients with chronic hepatitis C virus infection, where degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy.

The JPC agreed to support the attached East of England Priorities Advisory Committee (EoEPAC) Guidance Statement.

Full details available upon request – contact Medicines Optimisation team

Please use the search box to search the whole site if you can't find what you're looking for:

To top